Emily English - 15 Apr 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Operations Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Issuer symbol
RNAC
Transactions as of
15 Apr 2025
Net transactions value
+$24,750
Form type
4
Filing time
16 Apr 2025, 16:35:51 UTC
Previous filing
07 Jan 2025
Next filing
14 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Options Exercise $24,750 +7,500 +19% $3.30 47,726 15 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Options Exercise -7,500 -15% 41,869 15 Apr 2025 Common Stock 7,500 $3.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are currently fully vested and exercisable.
F2 On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.